LAUNXP Biomedical Co., Ltd

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

N/A

Website

www.launxp.com

Country

Taiwan

Exchange

Taipei Exchange

Founded 2015

LAUNXP Biomedical provides the research and development of drugs for cancer patients. It develops various drugs, which are in preclinical stage, including LXP5948 for non-small cell lung cancer and Alzheimer's disease.

Its portfolio also includes LXP5268 for triple negative breast cancer, LXP5101 for pancreatic cancer, LXP1788 for gastrointestinal cancer, and Virus-like particles for cancer and genetic defect treatment. Founded in 2015, the company is based in Taichung, Taiwan.

Key Stats

52-Week Range

NT$13.40NT$27.00

BetaN/A

Trailing P/EN/A

Forward P/EN/A

Trailing EPS-2.78

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.